SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095527
Filing Date
2024-08-12
Accepted
2024-08-12 17:05:19
Documents
54
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20240630.htm   iXBRL 10-Q 2140304
2 EX-31.1 dyn-ex31_1.htm EX-31.1 12133
3 EX-31.2 dyn-ex31_2.htm EX-31.2 11753
4 EX-32.1 dyn-ex32_1.htm EX-32.1 6157
5 EX-32.2 dyn-ex32_2.htm EX-32.2 6075
  Complete submission text file 0000950170-24-095527.txt   6541130

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dyn-20240630.xsd EX-101.SCH 786218
56 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20240630_htm.xml XML 966818
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 241197822
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)